China Resources Pharmaceutical Holdings, 3.5% 23jun2024, CNY (FIGI BBG011FW9SJ8, 102101168, CND10004GVJ5)
国内債券
国内債券
|
China Resources Pharmaceutical Group (hereinafter ‘CR Pharma’) is one of the leading pharmaceutical companies in China and engaged in the whole drug industrial chain including R&D, manufacturing, and distribution, with $103.65 billion HKD in total asset, ...
China Resources Pharmaceutical Group (hereinafter ‘CR Pharma’) is one of the leading pharmaceutical companies in China and engaged in the whole drug industrial chain including R&D, manufacturing, and distribution, with $103.65 billion HKD in total asset, $114.8 billion in main business turnover and $5.3 billion in net profit in the year of 2013.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡